IN157280B - - Google Patents
Info
- Publication number
- IN157280B IN157280B IN226/BOM/83A IN226BO1983A IN157280B IN 157280 B IN157280 B IN 157280B IN 226BO1983 A IN226BO1983 A IN 226BO1983A IN 157280 B IN157280 B IN 157280B
- Authority
- IN
- India
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN226/BOM/83A IN157280B (ja) | 1983-07-15 | 1983-07-15 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN226/BOM/83A IN157280B (ja) | 1983-07-15 | 1983-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN157280B true IN157280B (ja) | 1986-02-22 |
Family
ID=11078656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN226/BOM/83A IN157280B (ja) | 1983-07-15 | 1983-07-15 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN157280B (ja) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596726B1 (en) | 1994-01-25 | 2003-07-22 | Warner Lambert Company | Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| US6878716B1 (en) | 1998-06-02 | 2005-04-12 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptor and uses thereof |
| US7160890B2 (en) | 1999-12-02 | 2007-01-09 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| US7429574B2 (en) | 1998-06-02 | 2008-09-30 | Osi Pharmaceuticals, Inc. | 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| US7501407B2 (en) | 2001-12-20 | 2009-03-10 | Osi Pharmaceuticals, Inc. | Pyrimidine A2B selective antagonist compounds, their synthesis and use |
| US7504407B2 (en) | 2001-11-30 | 2009-03-17 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| US7598252B2 (en) | 2000-12-01 | 2009-10-06 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A, receptors and uses thereof |
| US7645754B2 (en) | 2001-12-20 | 2010-01-12 | Osi Pharmaceuticals, Inc. | Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| WO2014043272A1 (en) * | 2012-09-12 | 2014-03-20 | Trius Therapeutics Inc. | Tricyclic gyrase inhibitors for use as antibacterial agents |
| US9732083B2 (en) | 2011-03-15 | 2017-08-15 | Merck Sharp & Dohme Corp. | Tricyclic gyrase inhibitors |
| US9802955B2 (en) | 2007-08-27 | 2017-10-31 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
-
1983
- 1983-07-15 IN IN226/BOM/83A patent/IN157280B/en unknown
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596726B1 (en) | 1994-01-25 | 2003-07-22 | Warner Lambert Company | Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| US6878716B1 (en) | 1998-06-02 | 2005-04-12 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptor and uses thereof |
| US7429574B2 (en) | 1998-06-02 | 2008-09-30 | Osi Pharmaceuticals, Inc. | 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| US7160890B2 (en) | 1999-12-02 | 2007-01-09 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| US7598252B2 (en) | 2000-12-01 | 2009-10-06 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A, receptors and uses thereof |
| US7504407B2 (en) | 2001-11-30 | 2009-03-17 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| US7501407B2 (en) | 2001-12-20 | 2009-03-10 | Osi Pharmaceuticals, Inc. | Pyrimidine A2B selective antagonist compounds, their synthesis and use |
| US7645754B2 (en) | 2001-12-20 | 2010-01-12 | Osi Pharmaceuticals, Inc. | Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| US10414777B2 (en) | 2007-08-27 | 2019-09-17 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and method of use thereof |
| US9802955B2 (en) | 2007-08-27 | 2017-10-31 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| US9987283B2 (en) | 2007-08-27 | 2018-06-05 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| US10464944B2 (en) | 2007-08-27 | 2019-11-05 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| US10676483B2 (en) | 2007-08-27 | 2020-06-09 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| US11091500B2 (en) | 2007-08-27 | 2021-08-17 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| US9732083B2 (en) | 2011-03-15 | 2017-08-15 | Merck Sharp & Dohme Corp. | Tricyclic gyrase inhibitors |
| US10858360B2 (en) | 2011-03-15 | 2020-12-08 | Merck Sharp & Dohme Corp. | Tricyclic gyrase inhibitors |
| WO2014043272A1 (en) * | 2012-09-12 | 2014-03-20 | Trius Therapeutics Inc. | Tricyclic gyrase inhibitors for use as antibacterial agents |
| US10865216B2 (en) | 2012-09-12 | 2020-12-15 | Merck Sharp & Dohme Corp. | Tricyclic Gyrase inhibitors |